Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Patient preferences for attributes of primary surgical debulking versus neoadjuvant chemotherapy for treatment of newly diagnosed ovarian cancer.

Havrilesky LJ, Yang JC, Lee PS, Secord AA, Ehrisman JA, Davidson B, Berchuck A, Darcy KM, Maxwell GL, Reed SD.

Cancer. 2019 Aug 27. doi: 10.1002/cncr.32447. [Epub ahead of print]

PMID:
31454432
2.

Gender variation in Medicare utilization and payments in gynecologic oncology.

Lim SL, Puechl AM, Broadwater G, Ehrisman JA, Lorenzo A, Foote J, Davidson BA, Chino J, Havrilesky LJ.

Gynecol Oncol. 2019 Sep;154(3):602-607. doi: 10.1016/j.ygyno.2019.06.007. Epub 2019 Jul 12.

PMID:
31303256
3.

Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.

Veade AE, Foote J, Ehrisman J, Broadwater G, Davidson BA, Lee PS, Secord AA, Berchuck A, Havrilesky LJ.

World J Surg Oncol. 2019 May 10;17(1):80. doi: 10.1186/s12957-019-1620-x.

4.

A pilot study of lower extremity lymphedema, lower extremity function, and quality of life in women after minimally invasive endometrial cancer staging surgery.

Watson CH, Lopez-Acevedo M, Broadwater G, Kim AH, Ehrisman J, Davidson BA, Lee PS, Valea F, Berchuck A, Havrilesky LJ.

Gynecol Oncol. 2019 May;153(2):399-404. doi: 10.1016/j.ygyno.2019.02.021. Epub 2019 Mar 15.

PMID:
30879878
5.

Targeted composite value-based endpoints in platinum-sensitive recurrent ovarian cancer.

Foote JR, Secord AA, Liang MI, Ehrisman JA, Cohn DE, Jewell E, Havrilesky LJ.

Gynecol Oncol. 2019 Mar;152(3):445-451. doi: 10.1016/j.ygyno.2018.11.028.

PMID:
30876487
6.

Preferences of women with epithelial ovarian cancer for aspects of genetic testing.

Davidson BA, Ehrisman J, Reed SD, Yang JC, Buchanan A, Havrilesky LJ.

Gynecol Oncol Res Pract. 2019 Jan 22;6:1. doi: 10.1186/s40661-019-0066-8. eCollection 2019.

7.

The association between progesterone receptor expression and survival in women with adult granulosa cell tumors.

Puechl AM, Edwards J, Suri A, Nakayama J, Bean S, Gehrig P, Saks E, Duska L, Broadwater G, Ehrisman J, Horowitz N, Secord AA.

Gynecol Oncol. 2019 Apr;153(1):74-79. doi: 10.1016/j.ygyno.2019.01.016. Epub 2019 Jan 18.

PMID:
30661765
8.

Safety and feasibility of contained uterine morcellation in women undergoing laparoscopic hysterectomy.

Dotson S, Landa A, Ehrisman J, Secord AA.

Gynecol Oncol Res Pract. 2018 Oct 30;5:8. doi: 10.1186/s40661-018-0065-1. eCollection 2018.

9.

Multidisciplinary approach to manage antenatally suspected placenta percreta: updated algorithm and patient outcomes.

Lee PS, Kempner S, Miller M, Dominguez J, Grotegut C, Ehrisman J, Previs R, Havrilesky LJ, Broadwater G, Ellestad SC, Secord AA.

Gynecol Oncol Res Pract. 2017 Aug 22;4:11. doi: 10.1186/s40661-017-0049-6. eCollection 2017.

10.

Prospective Evaluation of Lymph Node Processing at Staging Surgery for High-grade Endometrial Cancer.

Davidson BA, Ehrisman J, Abbott S, Harmon Z, Secord AA, Berchuck A, Lee PS, Valea FA, Li X, Havrilesky LJ, Hall AHS.

Int J Gynecol Pathol. 2018 May;37(3):252-255. doi: 10.1097/PGP.0000000000000418.

PMID:
28700428
11.

Performance of sentinel lymph node biopsy in high-risk endometrial cancer.

Ehrisman J, Secord AA, Berchuck A, Lee PS, Di Santo N, Lopez-Acevedo M, Broadwater G, Valea FA, Havrilesky LJ.

Gynecol Oncol Rep. 2016 Apr 19;17:69-71. doi: 10.1016/j.gore.2016.04.002. eCollection 2016 Aug.

12.

Tumor grade and chemotherapy response in endometrioid endometrial cancer.

Davidson BA, Foote J, Clark LH, Broadwater G, Ehrisman J, Gehrig P, Graybill W, Alvarez Secord A, Havrilesky LJ.

Gynecol Oncol Rep. 2016 Apr 27;17:3-6. doi: 10.1016/j.gore.2016.04.006. eCollection 2016 Aug.

13.

Impact of postoperative nausea and vomiting prophylaxis with dexamethasone on the risk of recurrence of endometrial cancer.

Merk BA, Havrilesky LJ, Ehrisman JA, Broadwater G, Habib AS.

Curr Med Res Opin. 2016;32(3):453-8. doi: 10.1185/03007995.2015.1123146. Epub 2016 Jan 1.

PMID:
26583436
14.

Lumbee Native American ancestry and the incidence of aggressive histologic subtypes of endometrial cancer.

Zhang C, Roque D, Ehrisman JA, DiSanto N, Broadwater G, Doll KM, Gehrig PA, Secord AA, Havrilesky LJ.

Gynecol Oncol Rep. 2015 Jun 18;13:49-52. doi: 10.1016/j.gore.2015.06.004. eCollection 2015 Aug.

15.

Postoperative Pain Scores and Narcotic Use in Robotic-assisted Versus Laparoscopic Hysterectomy for Endometrial Cancer Staging.

Turner TB, Habib AS, Broadwater G, Valea FA, Fleming ND, Ehrisman JA, Di Santo N, Havrilesky LJ.

J Minim Invasive Gynecol. 2015 Sep-Oct;22(6):1004-10. doi: 10.1016/j.jmig.2015.05.003. Epub 2015 May 9.

PMID:
25967934
16.

A functional perspective of nitazoxanide as a potential anticancer drug.

Di Santo N, Ehrisman J.

Mutat Res. 2014 Oct;768:16-21. doi: 10.1016/j.mrfmmm.2014.05.005. Epub 2014 Jun 2. Review.

PMID:
25847384
17.

Vaginal cuff thermal injury by mode of colpotomy at total laparoscopic hysterectomy: a randomized clinical trial.

Teoh D, Lowery WJ, Jiang X, Ehrisman J, Halvorson P, Broadwater G, Bentley R, Secord AA, Sobolewski C, Berchuck A, Havrilesky LJ, Valea FA, Lee PS.

J Minim Invasive Gynecol. 2015 Feb;22(2):227-33. doi: 10.1016/j.jmig.2014.10.002. Epub 2014 Oct 8.

PMID:
25305572
18.

Patient preferences in advanced or recurrent ovarian cancer.

Havrilesky LJ, Alvarez Secord A, Ehrisman JA, Berchuck A, Valea FA, Lee PS, Gaillard SL, Samsa GP, Cella D, Weinfurt KP, Abernethy AP, Reed SD.

Cancer. 2014 Dec 1;120(23):3651-9. doi: 10.1002/cncr.28940. Epub 2014 Aug 4.

19.

Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patients.

Zhang C, Havrilesky LJ, Broadwater G, Di Santo N, Ehrisman JA, Lee PS, Berchuck A, Alvarez Secord A, Bean S, Bentley RC, Valea FA.

Gynecol Oncol. 2014 May;133(2):211-5. doi: 10.1016/j.ygyno.2014.02.025. Epub 2014 Feb 28.

PMID:
24582867
20.

Research perspective: potential role of nitazoxanide in ovarian cancer treatment. Old drug, new purpose?

Di Santo N, Ehrisman J.

Cancers (Basel). 2013 Sep 10;5(3):1163-76. doi: 10.3390/cancers5031163.

Supplemental Content

Loading ...
Support Center